Compounds > anipamil
Page last updated: 2024-08-23

anipamil and Body Weight

anipamil has been researched along with Body Weight in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frandsen, H; Hansen, BF; Hansen, JF; Mortensen, A1
Chan, L; Jarusiripipat, C; Schrier, RW; Shapiro, JI1

Other Studies

2 other study(ies) available for anipamil and Body Weight

ArticleYear
(-)-anipamil retards atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:3

    Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Calcium Channel Blockers; Cholesterol; Disease Models, Animal; Eating; Hyperlipidemia, Familial Combined; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Propylamines; Rabbits; Stereoisomerism

1995
Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 260, Issue:1

    Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Hydralazine; Kidney; Male; Nephrectomy; Propylamines; Rats; Rats, Inbred Strains; Time Factors; Uremia

1992